TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Menotropin Market 2012-2016: One of the Major Drivers is the Increasing Cases of Infertility

[December 19, 2013]

Research and Markets: Global Menotropin Market 2012-2016: One of the Major Drivers is the Increasing Cases of Infertility

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global Menotropin Market 2012-2016" report to their offering.

The analysts forecast the Global Menotropin market to grow at a CAGR of 1.315 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of infertility cases. The Global Menotropin market has also been witnessing an increasing number of awareness programs on the prevention and treatment of infertility. However, the adverse side effects of menotropins could pose a challenge to the growth of this market.

The key vendors dominating this space Ferring Pharmaceuticals Inc. and Merck Serono S.A.

The other vendors mentioned in the report are Angelini Farmaceutica S.A.,Bharat Serums and Vaccines Ltd., Emcure Pharmaceuticals Ltd., Fuji Yakuhin Co. Ltd., GP-Pharm S.A., LG Life Sciences India Pvt. Ltd., Mochida Pharmaceutical Co. Ltd., Neiss Labs Ltd., Sanzyme Ltd., Win Medicare Pvt. Ltd., and Zydus Cadila Healthcare Ltd.

Commenting on the report, an analyst from the Healthcare team said: The most common trend in the Global Menotropin market is the increase in the number of awareness programs regarding the prevention and treatment of infertility. These programs are conducted by various governmental and non-governmental organizations. For instance, The National Infertility Association celebrates National Infertility Awareness Week worldwide from April 21 to 27. Such awareness campaigns are educating people about the various technologies available to treat infertility. Moreover, Merck Serono, which produces numerous drugs used to treat fertility, embarked on a campaign in April 2013 called "Hope for Starting Families" to increase awareness on infertility and its treatment in the Philippines. Such awareness programs are expected to trigger the growth of the market.

Further, the report states that the availability of alternative treatment options such as other fertility drugs, IVF procedures, surrogacy, and intracytoplasmic sperm injection is hampering the growth of the Global Menotropin market. The key drug therapies include clomiphene citrate, hCG, GnRH antagonists, hMG, and FSH. All these therapies that are available to treat infertility in women are highly efficacious and safe.

For more information visit

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ Back To Technology News's Homepage ]


Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2014 Technology Marketing Corporation. All rights reserved.